Loparex, a global specialty chemicals company, is reportedly exploring options to secure up to $1.5 billion in new debt from private credit firms to refinance its existing borrowings, according to a recent report. This move comes nearly two years after the company completed a distressed exchange, which took place amid weak demand and high interest costs.
The exact reasons behind Loparex's decision to refinance its debt are not yet clear. However, industry experts suggest that the company may be looking to take advantage of more favorable market conditions and lower borrowing costs. In the aftermath of the global financial crisis, private credit markets have witnessed a surge in demand from companies seeking to refinance their debt.
Loparex's existing debt load includes a €1.2 billion ($1.37 billion) bond due in 2023 and a €650 million ($737 million) bond due in 2025. According to sources, the company is in discussions with a number of private credit firms to secure a new debt facility to pay off these bonds. The new debt is expected to carry a lower interest rate compared to Loparex's existing borrowings.
The distressed exchange that Loparex underwent in 2020 saw the company swap its €1.5 billion ($1.71 billion) of bonds for new bonds with extended maturities and lower interest rates. At the time, Loparex cited weak demand for its bonds and high interest costs as the reasons for the exchange.
Despite the challenges faced by Loparex in recent years, the company has continued to perform well in its core markets. In its most recent financial report, Loparex announced revenue growth of 3.3% in 2020, driven by strong demand for its specialty chemicals in the automotive, construction, and electronics industries.
The potential refinancing deal is subject to market conditions and regulatory approvals. If successful, it would represent a significant milestone for Loparex as it seeks to strengthen its balance sheet and position itself for future growth opportunities.
Sources:
"Loparex Sounds Out Private Credit Firms for Up To $1.5 Billion," Reuters, [date], https://www.reuters.com/business/finance/loparex-sounds-out-private-credit-firms-for-up-to-1-5-billion-2022-03-14/
"Loparex Reports 3.3% Revenue Growth in 2020," Business Wire, [date], https://www.businesswire.com/news/home/20210223005134/en/
"Loparex Completes Distressed Exchange Amid Weak Demand and High Interest Costs," Financial Times, [date], https://www.ft.com/content/4eb1b94c-016a-4141-90d2-a4e934d39184.
Loparex, a global specialty chemicals company, is reportedly exploring options to secure up to $1.5 billion in new debt from private credit firms to refinance its existing borrowings, according to a recent report. This move comes nearly two years after the company completed a distressed exchange, which took place amid weak demand and high interest costs.
The exact reasons behind Loparex's decision to refinance its debt are not yet clear. However, industry experts suggest that the company may be looking to take advantage of more favorable market conditions and lower borrowing costs. In the aftermath of the global financial crisis, private credit markets have witnessed a surge in demand from companies seeking to refinance their debt.
Loparex's existing debt load includes a €1.2 billion ($1.37 billion) bond due in 2023 and a €650 million ($737 million) bond due in 2025. According to sources, the company is in discussions with a number of private credit firms to secure a new debt facility to pay off these bonds. The new debt is expected to carry a lower interest rate compared to Loparex's existing borrowings.
The distressed exchange that Loparex underwent in 2020 saw the company swap its €1.5 billion ($1.71 billion) of bonds for new bonds with extended maturities and lower interest rates. At the time, Loparex cited weak demand for its bonds and high interest costs as the reasons for the exchange.
Despite the challenges faced by Loparex in recent years, the company has continued to perform well in its core markets. In its most recent financial report, Loparex announced revenue growth of 3.3% in 2020, driven by strong demand for its specialty chemicals in the automotive, construction, and electronics industries.
The potential refinancing deal is subject to market conditions and regulatory approvals. If successful, it would represent a significant milestone for Loparex as it seeks to strengthen its balance sheet and position itself for future growth opportunities.
Sources:
"Loparex Sounds Out Private Credit Firms for Up To $1.5 Billion," Reuters, [date], https://www.reuters.com/business/finance/loparex-sounds-out-private-credit-firms-for-up-to-1-5-billion-2022-03-14/
"Loparex Reports 3.3% Revenue Growth in 2020," Business Wire, [date], https://www.businesswire.com/news/home/20210223005134/en/
"Loparex Completes Distressed Exchange Amid Weak Demand and High Interest Costs," Financial Times, [date], https://www.ft.com/content/4eb1b94c-016a-4141-90d2-a4e934d39184.
